B-COMPLEX #3 W/PRES recalled over sterility concerns
- Recall date
- May 13, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Medaus, Inc. recalls B-COMPLEX #3 W/PRES (BENZYL ETOH 2%), B1-100MG, B2-5-PO4-2MG, B3-100MG, B5-2MG, B6-2MG/ML, 10ML Vials, MEDAUS PHARMACY
- Recall number
- D-1168-2016
- FDA classification
- Class II
- Brand / firm
- Medaus, Inc.
- Sold / distributed
- U.S. Nationwide, Japan, and New Zealand.
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
B-COMPLEX #3 W/PRES (BENZYL ETOH 2%), B1-100MG, B2-5-PO4-2MG, B3-100MG, B5-2MG, B6-2MG/ML, 10ML Vials, MEDAUS PHARMACY
Get recall alerts
Free email alert whenever Medaus, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Medaus, Inc.